China Synthesis Polypeptide Drug Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Synthesis Polypeptide Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Ipsen PHarma Biotech

    • Asahi Kasei

    • Wuhan Hualong Bio-Chemical Pharmaceutical Co,Ltd

    • Takeda

    • Sichuan Chengdu Diao Pharmaceutical Group Co,Ltd

    • Beijing Shuanglu Pharmaceutical Co,Ltd

    • Hainan Shuangcheng Pharmaceuticals Co,Ltd

    • Beijing Yingu Century Pharmaceutical Co,Ltd (Beijing Shiqiao Bio-Pharmaceutical Co,Ltd)

    • Hainan Zhonghe Pharmaceutical Co,Ltd

    • Changzhou Siyao Pharmaceutical Co,Ltd

    • Ferring Pharmaceuticals

    • Livzon Pharmaceuticals Co,Ltd

    • AstraZeneca

    • Chengdu Tiantaishan Pharmaceutical Co,Ltd

    • Lilly

    • Yangzijiang Pharmaceutical Co,Ltd

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By Application:

    • Application 1

    • Application 2

    • Application 3

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Synthesis Polypeptide Drug Market Overview 2018-2029

    • 1.1 China Synthesis Polypeptide Drug Industry Development Overview

    • 1.2 China Synthesis Polypeptide Drug Industry Development History

    • 1.3 China Synthesis Polypeptide Drug Industry Market Size (2018-2029)

    • 1.4 China Synthesis Polypeptide Drug Market Analysis by Type from Production Side

      • 1.4.1 China Synthesis Polypeptide Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

      • 1.4.2 China Synthesis Polypeptide Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

      • 1.4.3 China Synthesis Polypeptide Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • 1.5 China Synthesis Polypeptide Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Synthesis Polypeptide Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

      • 1.5.2 China Synthesis Polypeptide Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

      • 1.5.3 China Synthesis Polypeptide Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • 1.6 China Synthesis Polypeptide Drug Market Analysis by Region

      • 1.6.1 North China Synthesis Polypeptide Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Synthesis Polypeptide Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Synthesis Polypeptide Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Synthesis Polypeptide Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Synthesis Polypeptide Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Synthesis Polypeptide Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Synthesis Polypeptide Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Synthesis Polypeptide Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Synthesis Polypeptide Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Synthesis Polypeptide Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Synthesis Polypeptide Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Synthesis Polypeptide Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Synthesis Polypeptide Drug Industry Development

    Chapter 3 Synthesis Polypeptide DrugIndustry Chain Analysis

    • 3.1 Synthesis Polypeptide Drug Industry Chain

    • 3.2 Synthesis Polypeptide Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Synthesis Polypeptide Drug Market

    • 3.3 Synthesis Polypeptide Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Synthesis Polypeptide Drug Market

    Chapter 4 China Synthesis Polypeptide Drug Market, by Type

    • 4.1 China Synthesis Polypeptide Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Synthesis Polypeptide Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Synthesis Polypeptide Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Synthesis Polypeptide Drug Production Volume and Growth Rate of Type 1

      • 4.5.2 China Synthesis Polypeptide Drug Production Volume and Growth Rate of Type 2

      • 4.5.3 China Synthesis Polypeptide Drug Production Volume and Growth Rate of Type 3

    Chapter 5 China Synthesis Polypeptide Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Synthesis Polypeptide Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Synthesis Polypeptide Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Synthesis Polypeptide Drug Market Size and Growth Rate of Application 1

      • 5.5.2 China Synthesis Polypeptide Drug Market Size and Growth Rate of Application 2

      • 5.5.3 China Synthesis Polypeptide Drug Market Size and Growth Rate of Application 3

    Chapter 6 China Synthesis Polypeptide Drug Market, by Region

    • 6.1 China Synthesis Polypeptide Drug Production Volume and Production Value, by Region

    • 6.2 China Synthesis Polypeptide Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Synthesis Polypeptide Drug Market Analysis

    • 7.1 North China Synthesis Polypeptide Drug Market, by Type

    • 7.2 North China Synthesis Polypeptide Drug Market, by Application

    Chapter 8 Central China Synthesis Polypeptide Drug Market Analysis

    • 8.1 Central China Synthesis Polypeptide Drug Market, by Type

    • 8.2 Central China Synthesis Polypeptide Drug Market, by Application

    Chapter 9 South China Synthesis Polypeptide Drug Market Analysis

    • 9.1 South China Synthesis Polypeptide Drug Market, by Type

    • 9.2 South China Synthesis Polypeptide Drug Market, by Application

    Chapter 10 East China Synthesis Polypeptide Drug Market Analysis

    • 10.1 East China Synthesis Polypeptide Drug Market, by Type

    • 10.2 East China Synthesis Polypeptide Drug Market, by Application

    Chapter 11 Northeast China Synthesis Polypeptide Drug Market Analysis

    • 11.1 Northeast China Synthesis Polypeptide Drug Market, by Type

    • 11.2 Northeast China Synthesis Polypeptide Drug Market, by Application

    Chapter 12 Southwest China Synthesis Polypeptide Drug Market Analysis

    • 12.1 Southwest China Synthesis Polypeptide Drug Market, by Type

    • 12.2 Southwest China Synthesis Polypeptide Drug Market, by Application

    Chapter 13 Northwest China Synthesis Polypeptide Drug Market Analysis

    • 13.1 Northwest China Synthesis Polypeptide Drug Market, by Type

    • 13.2 Northwest China Synthesis Polypeptide Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Ipsen PHarma Biotech

        • 14.1.1 Ipsen PHarma Biotech Company Profile

        • 14.1.2 Ipsen PHarma Biotech Synthesis Polypeptide Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Asahi Kasei

        • 14.2.1 Asahi Kasei Company Profile

        • 14.2.2 Asahi Kasei Synthesis Polypeptide Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Wuhan Hualong Bio-Chemical Pharmaceutical Co,Ltd

        • 14.3.1 Wuhan Hualong Bio-Chemical Pharmaceutical Co,Ltd Company Profile

        • 14.3.2 Wuhan Hualong Bio-Chemical Pharmaceutical Co,Ltd Synthesis Polypeptide Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Takeda

        • 14.4.1 Takeda Company Profile

        • 14.4.2 Takeda Synthesis Polypeptide Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Sichuan Chengdu Diao Pharmaceutical Group Co,Ltd

        • 14.5.1 Sichuan Chengdu Diao Pharmaceutical Group Co,Ltd Company Profile

        • 14.5.2 Sichuan Chengdu Diao Pharmaceutical Group Co,Ltd Synthesis Polypeptide Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Beijing Shuanglu Pharmaceutical Co,Ltd

        • 14.6.1 Beijing Shuanglu Pharmaceutical Co,Ltd Company Profile

        • 14.6.2 Beijing Shuanglu Pharmaceutical Co,Ltd Synthesis Polypeptide Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Hainan Shuangcheng Pharmaceuticals Co,Ltd

        • 14.7.1 Hainan Shuangcheng Pharmaceuticals Co,Ltd Company Profile

        • 14.7.2 Hainan Shuangcheng Pharmaceuticals Co,Ltd Synthesis Polypeptide Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Beijing Yingu Century Pharmaceutical Co,Ltd (Beijing Shiqiao Bio-Pharmaceutical Co,Ltd)

        • 14.8.1 Beijing Yingu Century Pharmaceutical Co,Ltd (Beijing Shiqiao Bio-Pharmaceutical Co,Ltd) Company Profile

        • 14.8.2 Beijing Yingu Century Pharmaceutical Co,Ltd (Beijing Shiqiao Bio-Pharmaceutical Co,Ltd) Synthesis Polypeptide Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Hainan Zhonghe Pharmaceutical Co,Ltd

        • 14.9.1 Hainan Zhonghe Pharmaceutical Co,Ltd Company Profile

        • 14.9.2 Hainan Zhonghe Pharmaceutical Co,Ltd Synthesis Polypeptide Drug Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Changzhou Siyao Pharmaceutical Co,Ltd

        • 14.10.1 Changzhou Siyao Pharmaceutical Co,Ltd Company Profile

        • 14.10.2 Changzhou Siyao Pharmaceutical Co,Ltd Synthesis Polypeptide Drug Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Ferring Pharmaceuticals

        • 14.11.1 Ferring Pharmaceuticals Company Profile

        • 14.11.2 Ferring Pharmaceuticals Synthesis Polypeptide Drug Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Livzon Pharmaceuticals Co,Ltd

        • 14.12.1 Livzon Pharmaceuticals Co,Ltd Company Profile

        • 14.12.2 Livzon Pharmaceuticals Co,Ltd Synthesis Polypeptide Drug Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 AstraZeneca

        • 14.13.1 AstraZeneca Company Profile

        • 14.13.2 AstraZeneca Synthesis Polypeptide Drug Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Chengdu Tiantaishan Pharmaceutical Co,Ltd

        • 14.14.1 Chengdu Tiantaishan Pharmaceutical Co,Ltd Company Profile

        • 14.14.2 Chengdu Tiantaishan Pharmaceutical Co,Ltd Synthesis Polypeptide Drug Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Lilly

        • 14.15.1 Lilly Company Profile

        • 14.15.2 Lilly Synthesis Polypeptide Drug Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Yangzijiang Pharmaceutical Co,Ltd

        • 14.16.1 Yangzijiang Pharmaceutical Co,Ltd Company Profile

        • 14.16.2 Yangzijiang Pharmaceutical Co,Ltd Synthesis Polypeptide Drug Market Performance

        • 14.16.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Synthesis Polypeptide Drug Industry Research Conclusions

    • 15.2 Synthesis Polypeptide Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Synthesis Polypeptide Drug Industry Market Size (2018-2029)

    • Figure China Synthesis Polypeptide Drug Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

    • Figure China Synthesis Polypeptide Drug Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

    • Figure China Synthesis Polypeptide Drug Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • Figure China Synthesis Polypeptide Drug Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

    • Figure China Synthesis Polypeptide Drug Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

    • Figure China Synthesis Polypeptide Drug Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • Figure North China Synthesis Polypeptide Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Synthesis Polypeptide Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Synthesis Polypeptide Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Synthesis Polypeptide Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Synthesis Polypeptide Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Synthesis Polypeptide Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Synthesis Polypeptide Drug Market Size and Growth Rate from 2018-2029

    • Figure Synthesis Polypeptide Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Synthesis Polypeptide Drug Market Share by Type in 2018

    • Figure China Synthesis Polypeptide Drug Market Share by Type in 2023

    • Figure China Synthesis Polypeptide Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Synthesis Polypeptide Drug Production Volume and Growth Rate of Type 1 (2018-2023)

    • Figure China Synthesis Polypeptide Drug Production Volume and Growth Rate of Type 2 (2018-2023)

    • Figure China Synthesis Polypeptide Drug Production Volume and Growth Rate of Type 3 (2018-2023)

    • Figure China Synthesis Polypeptide Drug Market Share by Application in 2018

    • Figure China Synthesis Polypeptide Drug Market Share by Application in 2023

    • Figure China Synthesis Polypeptide Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Synthesis Polypeptide Drug Market Size and Growth Rate of Application 1 (2018-2023)

    • Figure China Synthesis Polypeptide Drug Market Size and Growth Rate of Application 2 (2018-2023)

    • Figure China Synthesis Polypeptide Drug Market Size and Growth Rate of Application 3 (2018-2023)

    • Table China Synthesis Polypeptide Drug Production Volume by Region (2018-2023)

    • Table China Synthesis Polypeptide Drug Production Volume Share by Region (2018-2023)

    • Figure China Synthesis Polypeptide Drug Production Volume Share by Region (2018-2023)

    • Table China Synthesis Polypeptide Drug Production Value by Region (2018-2023)

    • Table China Synthesis Polypeptide Drug Production Value Share by Region (2018-2023)

    • Figure China Synthesis Polypeptide Drug Production Value Share by Region (2018-2023)

    • Table China Synthesis Polypeptide Drug Sales Volume by Region (2018-2023)

    • Table China Synthesis Polypeptide Drug Sales Volume Share by Region (2018-2023)

    • Figure China Synthesis Polypeptide Drug Sales Volume Share by Region (2018-2023)

    • Table China Synthesis Polypeptide Drug Sales Value by Region (2018-2023)

    • Table China Synthesis Polypeptide Drug Sales Value Share by Region (2018-2023)

    • Figure China Synthesis Polypeptide Drug Sales Value Share by Region (2018-2023)

    • Table North China Synthesis Polypeptide Drug Production Volume by Type (2018-2023)

    • Table North China Synthesis Polypeptide Drug Production Volume Share by Type (2018-2023)

    • Figure North China Synthesis Polypeptide Drug Production Volume Share by Type (2018-2023)

    • Table North China Synthesis Polypeptide Drug Sales Volume by Application (2018-2023)

    • Table North China Synthesis Polypeptide Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Synthesis Polypeptide Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Synthesis Polypeptide Drug Production Volume by Type (2018-2023)

    • Table Central China Synthesis Polypeptide Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Synthesis Polypeptide Drug Production Volume Share by Type (2018-2023)

    • Table Central China Synthesis Polypeptide Drug Sales Volume by Application (2018-2023)

    • Table Central China Synthesis Polypeptide Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Synthesis Polypeptide Drug Sales Volume Share by Application (2018-2023)

    • Table South China Synthesis Polypeptide Drug Production Volume by Type (2018-2023)

    • Table South China Synthesis Polypeptide Drug Production Volume Share by Type (2018-2023)

    • Figure South China Synthesis Polypeptide Drug Production Volume Share by Type (2018-2023)

    • Table South China Synthesis Polypeptide Drug Sales Volume by Application (2018-2023)

    • Table South China Synthesis Polypeptide Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Synthesis Polypeptide Drug Sales Volume Share by Application (2018-2023)

    • Table East China Synthesis Polypeptide Drug Production Volume by Type (2018-2023)

    • Table East China Synthesis Polypeptide Drug Production Volume Share by Type (2018-2023)

    • Figure East China Synthesis Polypeptide Drug Production Volume Share by Type (2018-2023)

    • Table East China Synthesis Polypeptide Drug Sales Volume by Application (2018-2023)

    • Table East China Synthesis Polypeptide Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Synthesis Polypeptide Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Synthesis Polypeptide Drug Production Volume by Type (2018-2023)

    • Table Northeast China Synthesis Polypeptide Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Synthesis Polypeptide Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Synthesis Polypeptide Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Synthesis Polypeptide Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Synthesis Polypeptide Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Synthesis Polypeptide Drug Production Volume by Type (2018-2023)

    • Table Southwest China Synthesis Polypeptide Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Synthesis Polypeptide Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Synthesis Polypeptide Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Synthesis Polypeptide Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Synthesis Polypeptide Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Synthesis Polypeptide Drug Production Volume by Type (2018-2023)

    • Table Northwest China Synthesis Polypeptide Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Synthesis Polypeptide Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Synthesis Polypeptide Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Synthesis Polypeptide Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Synthesis Polypeptide Drug Sales Volume Share by Application (2018-2023)

    • Table Ipsen PHarma Biotech Company Profile

    • Table Ipsen PHarma Biotech Synthesis Polypeptide Drug Revenue, Price and Gross (2018-2023)

    • Table Asahi Kasei Company Profile

    • Table Asahi Kasei Synthesis Polypeptide Drug Revenue, Price and Gross (2018-2023)

    • Table Wuhan Hualong Bio-Chemical Pharmaceutical Co,Ltd Company Profile

    • Table Wuhan Hualong Bio-Chemical Pharmaceutical Co,Ltd Synthesis Polypeptide Drug Revenue, Price and Gross (2018-2023)

    • Table Takeda Company Profile

    • Table Takeda Synthesis Polypeptide Drug Revenue, Price and Gross (2018-2023)

    • Table Sichuan Chengdu Diao Pharmaceutical Group Co,Ltd Company Profile

    • Table Sichuan Chengdu Diao Pharmaceutical Group Co,Ltd Synthesis Polypeptide Drug Revenue, Price and Gross (2018-2023)

    • Table Beijing Shuanglu Pharmaceutical Co,Ltd Company Profile

    • Table Beijing Shuanglu Pharmaceutical Co,Ltd Synthesis Polypeptide Drug Revenue, Price and Gross (2018-2023)

    • Table Hainan Shuangcheng Pharmaceuticals Co,Ltd Company Profile

    • Table Hainan Shuangcheng Pharmaceuticals Co,Ltd Synthesis Polypeptide Drug Revenue, Price and Gross (2018-2023)

    • Table Beijing Yingu Century Pharmaceutical Co,Ltd (Beijing Shiqiao Bio-Pharmaceutical Co,Ltd) Company Profile

    • Table Beijing Yingu Century Pharmaceutical Co,Ltd (Beijing Shiqiao Bio-Pharmaceutical Co,Ltd) Synthesis Polypeptide Drug Revenue, Price and Gross (2018-2023)

    • Table Hainan Zhonghe Pharmaceutical Co,Ltd Company Profile

    • Table Hainan Zhonghe Pharmaceutical Co,Ltd Synthesis Polypeptide Drug Revenue, Price and Gross (2018-2023)

    • Table Changzhou Siyao Pharmaceutical Co,Ltd Company Profile

    • Table Changzhou Siyao Pharmaceutical Co,Ltd Synthesis Polypeptide Drug Revenue, Price and Gross (2018-2023)

    • Table Ferring Pharmaceuticals Company Profile

    • Table Ferring Pharmaceuticals Synthesis Polypeptide Drug Revenue, Price and Gross (2018-2023)

    • Table Livzon Pharmaceuticals Co,Ltd Company Profile

    • Table Livzon Pharmaceuticals Co,Ltd Synthesis Polypeptide Drug Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Synthesis Polypeptide Drug Revenue, Price and Gross (2018-2023)

    • Table Chengdu Tiantaishan Pharmaceutical Co,Ltd Company Profile

    • Table Chengdu Tiantaishan Pharmaceutical Co,Ltd Synthesis Polypeptide Drug Revenue, Price and Gross (2018-2023)

    • Table Lilly Company Profile

    • Table Lilly Synthesis Polypeptide Drug Revenue, Price and Gross (2018-2023)

    • Table Yangzijiang Pharmaceutical Co,Ltd Company Profile

    • Table Yangzijiang Pharmaceutical Co,Ltd Synthesis Polypeptide Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.